Quoin Pharmaceuticals Statistics

Total Valuation

QNRX has a market cap or net worth of $8.94 million. The enterprise value is -$2.93 million.

Market Cap	8.94M
Enterprise Value	-2.93M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

QNRX has 2.01 million shares outstanding. The number of shares has increased by 518.76% in one year.

Current Share Class	n/a
Shares Outstanding	2.01M
Shares Change (YoY)	+518.76%
Shares Change (QoQ)	+13.50%
Owned by Insiders (%)	2.85%
Owned by Institutions (%)	46.20%
Float	1.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.99
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.25.

Current Ratio	2.87
Quick Ratio	2.63
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -231.18% and return on invested capital (ROIC) is -111.12%.

Return on Equity (ROE)	-231.18%
Return on Assets (ROA)	-76.20%
Return on Invested Capital (ROIC)	-111.12%
Return on Capital Employed (ROCE)	-168.79%
Weighted Average Cost of Capital (WACC)	10.86%
Revenue Per Employee	n/a
Profits Per Employee	-$2.83M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.46% in the last 52 weeks. The beta is 1.68, so QNRX's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-52.46%
50-Day Moving Average	5.26
200-Day Moving Average	9.31
Relative Strength Index (RSI)	47.07
Average Volume (20 Days)	683,666

Short Selling Information

The latest short interest is 48,916, so 2.44% of the outstanding shares have been sold short.

Short Interest	48,916
Short Previous Month	79,876
Short % of Shares Out	2.44%
Short % of Float	n/a
Short Ratio (days to cover)	1.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.46M
Pretax Income	-16.99M
Net Income	-16.99M
EBITDA	-17.36M
EBIT	-17.46M
Earnings Per Share (EPS)	-$10.43

Full Income Statement

Balance Sheet

The company has $14.04 million in cash and $2.17 million in debt, giving a net cash position of $11.87 million or $5.91 per share.

Cash & Cash Equivalents	14.04M
Total Debt	2.17M
Net Cash	11.87M
Net Cash Per Share	$5.91
Equity (Book Value)	8.77M
Book Value Per Share	4.47
Working Capital	9.99M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-15.82M
Capital Expenditures	n/a
Depreciation & Amortization	100,000
Net Borrowing	-600,000
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-518.76%
Shareholder Yield	-518.76%
Earnings Yield	-190.10%
FCF Yield	n/a

Analyst Forecast

The average price target for QNRX is $21.40, which is 380.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.40
Price Target Difference	380.90%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:35.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	1:35

Scores

Altman Z-Score	n/a
Piotroski F-Score	3